--- name: the-lancet-public-health description: Use when targeting The Lancet Public Health or deciding whether a population-health study fits this venue. Encodes the journal's fit, the population-level intervention, epidemiology, and policy evidence bar, reporting-guideline and registration requirements, Lancet specialty house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice. --- # The Lancet Public Health (the-lancet-public-health) ## Journal positioning The Lancet Public Health is a Lancet specialty journal for population and public-health research — population-level interventions, health policy and systems, epidemiology and disease burden, and global-health and health-equity research with population-level relevance. It favors **rigorous studies whose unit of interest and consequence is the population, not the individual patient**: large-scale epidemiology, policy and natural experiments, modelling with clear public-health decision value, and interventions addressing inequalities or the social determinants of health. The defining misfit is an individual-level clinical study (a drug or device effect in patients) with no population, policy, or equity dimension — that belongs in a clinical journal. This skill is a **fit / venue-selection / re-framing** aid; it is not clinical or regulatory advice and does not replace the journal's current instructions for authors. Before submitting, re-check the live The Lancet Public Health author instructions. ## When to trigger - The author names The Lancet Public Health for a population-health, epidemiology, or policy study and wants a fit/framing check. - A study must be re-framed around a population-level intervention, burden, or policy question with equity relevance. - The author is choosing between The Lancet Public Health, a clinical specialty journal, and general medicine. - The author needs the journal's reporting-guideline, registration, and desk-reject expectations for population/policy evidence. ## Scope & topic fit - Population-level interventions and policy/natural experiments (taxation, regulation, screening programmes, vaccination, public-health service delivery). - Epidemiology, disease-burden, surveillance, and risk-factor studies at population scale, including global and comparative analyses. - Health-systems, health-services, and health-economics research with population-level decision relevance. - Health-equity, social-determinants, and inequalities research with population-level framing and policy implication. - Modelling and forecasting studies (transmission, burden, intervention impact) with transparent assumptions and public-health decision value. - Systematic reviews and meta-analyses answering a focused population-health or policy question. ## Method & evidence bar - Studies must have a clear population-level question and an appropriate population denominator; individual-level clinical endpoints alone do not establish public-health relevance. - The applicable reporting guideline and completed checklist are expected: STROBE for observational studies, CONSORT (incl. cluster-CONSORT) for trials, PRISMA for reviews, GATHER for global-health estimates, and modelling-reporting standards where relevant. - Trials and pre-specified evaluations require prospective registration; protocols and analysis plans are expected, with cluster/stepped-wedge design detail where used. - Observational and natural-experiment claims must address confounding, secular trends, ecological bias, and missing data; causal language must match the design. - Modelling studies must state assumptions, perform sensitivity/uncertainty analysis, and report data sources transparently; code/data sharing strengthens the submission. - Effect estimates need uncertainty intervals and, where relevant, equity-stratified or absolute population-impact measures. ## Structure & house style - Lancet specialty format with a structured summary and a Research in context / evidence-before-this-study panel; re-check current article types and limits on the live guide. - The introduction frames the population-health or policy gap; the discussion states the policy or public-health consequence and limitations plainly. - A STROBE/CONSORT/PRISMA flow diagram and (for estimates) GATHER reporting are expected where applicable; tables/figures follow Lancet statistical-reporting standards. - The role of the funding source statement and a data-sharing statement are expected; appendices carry protocol/model specification, full methods, and additional analyses. ## Official-submission checklist - Before giving submission-ready advice, read `../../resources/source-basis.md` and `../../resources/official-source-map.md`; start from the ICMJE/EQUATOR and Lancet anchors, then cite the current The Lancet Public Health page you checked. - Search the live site for "The Lancet Public Health information for authors" and follow the current version. - Re-check article types, structured-summary and Research in context format, and word/reference/figure limits. - Confirm registration where applicable, the reporting checklist (STROBE/CONSORT/PRISMA/GATHER), protocol/model specification, role-of-funding-source, and data/code-sharing statement. - Re-check IRB/ethics and consent or data-governance approvals, ICMJE authorship and conflict-of-interest disclosure, funding, and AI-use disclosure. - If the live official instructions conflict with this skill, the official instructions win. ## Pre-submission self-check - [ ] The study has a genuine population-level question, denominator, and policy/equity consequence. - [ ] The correct reporting checklist (STROBE/CONSORT/PRISMA/GATHER) is completed and attached. - [ ] Trials/evaluations are registered where applicable; protocol or model specification is provided. - [ ] Confounding, secular trends, ecological bias, and missing data are addressed; causal language matches the design. - [ ] Modelling assumptions, uncertainty, and data sources are transparent; code/data sharing is planned. - [ ] Ethics/data-governance approvals, ICMJE disclosures, role-of-funding-source, and a data-sharing statement are prepared. ## Common desk-reject triggers - Individual-level clinical studies with no population, policy, or equity dimension. - Small or local descriptive surveys with no generalizable population-health implication. - Modelling with opaque assumptions, no sensitivity analysis, or undocumented data sources. - Ecological analyses with overstated individual-level causal claims. - Missing reporting checklist, registration (where applicable), or data-governance approvals. - Narrow scope without international or policy relevance, better suited to a regional or clinical venue. ## Re-routing decision - Individual-level clinical trial or patient-outcome focus → the relevant clinical specialty journal or general medicine (`jama` / NEJM / The Lancet in the natural-science bundle). - Population mental-health and psychiatric epidemiology dominant → `the-lancet-psychiatry`. - Diabetes/obesity population research with a clinical-metabolic core → `the-lancet-diabetes-and-endocrinology`. - Respiratory population/clinical research with a respiratory endpoint → `the-lancet-respiratory-medicine`. - Cancer epidemiology with a clinical-oncology endpoint → `annals-of-oncology` / `jama-oncology`. ## Output format ```text [Fit] High / Medium / Low (one-line reason) [Target] The Lancet Public Health [Specialty tags] <2–3 closest population-health/policy/epidemiology topics> [Study design / reporting guideline] [Method/evidence] [Top risk] [Official items to re-check]
[Re-route suggestion] ```